30/10/2025
The Future of Ready-to-Use Intravenous Solutions – Qatar Pharma Premix IV Solutions
In today’s healthcare world, speed, precision, and safety are essential pillars of effective hospital care. Qatar Pharma proudly introduces a new generation of Ready-to-Use Premix IV Solutions, engineered to meet the highest standards of quality and efficacy.
This innovation aligns with Qatar’s National Vision 2030 and the guidance of His Highness Sheikh Tamim Bin Hamad Al Thani, the Amir of the State of Qatar, emphasizing pharmaceutical self-sufficiency and national healthcare excellence.
💧 What Are Premix IV Solutions?
Premix IV solutions are sterile, ready-to-use intravenous fluids containing a balanced mix of:
Potassium Chloride (KCl)
Sodium Chloride (NaCl)
Dextrose (Glucose)
They are manufactured in a fully aseptic environment to ensure maximum safety, accuracy, and chemical stability.
⭐ Key Features:
✅ Ready for direct use – no need for manual mixing or preparation
✅ Minimizes contamination risk and medication errors
✅ Balanced formula for optimal fluid and electrolyte replacement
✅ Precise control of potassium and glucose concentrations for critical cases
✅ Extended shelf life with GMP and ISO-certified packaging
✅ Minimizes the cost (handwritten note in image)
🏥 Medical Applications:
Emergency and Intensive Care Units (ICU)
Treatment of hypokalemia or electrolyte imbalances
Parenteral nutritional support (TPN/PPN)
Fluid replacement after surgery or during IV therapy
🌍 Qatar Pharma – National Manufacturing with Global Standards
With state-of-the-art infrastructure and sterile production lines, Qatar Pharma stands among the region’s leading manufacturers of safe and effective pharmaceutical solutions. Our commitment supports Qatar’s Vision 2030 in achieving full pharmaceutical self-sufficiency.
🌟 Qatar Pharma’s Mission
At Qatar Pharma, we are dedicated to developing innovative medical products that place patient safety and treatment efficiency at the forefront—because every drop of our solution makes a difference in a patient’s life.
Under the leadership and insightful vision of Dr. Ahmed Bin Mohammed Al-Sulaiti – Chairman of Qatar Pharma.